WBUR News

Support the news

Promising Results In Early Trial of Novel MS Treatment11:25

Play

Reporting in the journal Science Translational Medicine researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe. Study co-author Stephen D. Miller of Northwestern University, describes the novel approach tested in this small, phase 1 clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type 1 diabetes.

+Join the discussion
Share

Support the news

Next Up

Where to now?

More NPR or Explore Audio.